Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Halahakoon DC"'
BackgroundDopamine D2-like receptor agonists show promise as treatments for depression. They are thought to act by altering how individuals learn from rewarding experiences. However, the nature of these reward learning alterations, and the mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29bf983af5964b3c07c121e2cc1664f2
https://doi.org/10.1101/2022.01.14.22269287
https://doi.org/10.1101/2022.01.14.22269287
Publikováno v:
The international journal of neuropsychopharmacology. 25(9)
Background Patients with Parkinson’s disease (PD) show impaired performance in taste recognition tests, which suggests a possible dopaminergic influence on gustatory functioning. To experimentally test this hypothesis, we assessed whether pharmacol
Publikováno v:
Nord, CL, Forster, S, Halahakoon, DC, Penton-Voak, I, Munafo, M & Roiser, J P 2017, ' Prefrontal cortex stimulation does not affect emotional bias, but may slow emotion identification ', Social Cognitive and Affective Neuroscience, vol. 2, no. 5, pp. 839–847 . https://doi.org/10.1093/scan/nsx007
Transcranial direct current stimulation (tDCS) has recently garnered attention as a putative depression treatment. However, the cognitive mechanisms by which it exerts an antidepressant effect are unclear: tDCS may directly alter ‘hot’ emotional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2642::22101e1a5476bafefb0f1e59aec9298a
https://research-information.bris.ac.uk/en/publications/44f466d5-8a0d-4ae9-b48a-40d283b4e7c2
https://research-information.bris.ac.uk/en/publications/44f466d5-8a0d-4ae9-b48a-40d283b4e7c2
Autor:
Au-Yeung SK; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK. sauyeung1@sheffield.ac.uk.; Clinical Psychology Unit, University of Sheffield, Cathedral Court Floor F 1 Vicar Lane, Sheffield, S1 2LT, UK. sauyeung1@sheffield.ac.uk., Halahakoon DC; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, OX3 7JX, UK., Kaltenboeck A; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK.; Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna General Hospital, Vienna, 1090, Austria., Cowen P; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK., Browning M; Department of Psychiatry, University of Oxford, Oxford, OX3 7JX, UK.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, OX3 7JX, UK., Manohar SG; Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, University of Oxford, Level 6 West Wing, Oxford, OX3 9DU, UK.
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2024 Jul; Vol. 241 (7), pp. 1365-1375. Date of Electronic Publication: 2024 Mar 18.
Autor:
Halahakoon DC; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Oxford Health National Health Service Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Kaltenboeck A; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria., Martens M; Department of Psychiatry, University of Oxford, Oxford, United Kingdom., Geddes JG; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Oxford Health National Health Service Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Harmer CJ; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Oxford Health National Health Service Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Cowen P; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Oxford Health National Health Service Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Browning M; Department of Psychiatry, University of Oxford, Oxford, United Kingdom; Oxford Health National Health Service Foundation Trust, Warneford Hospital, Oxford, United Kingdom. Electronic address: michael.browning@psych.ox.ac.uk.
Publikováno v:
Biological psychiatry [Biol Psychiatry] 2024 Feb 01; Vol. 95 (3), pp. 286-296. Date of Electronic Publication: 2023 Jun 15.
Autor:
Halahakoon DC; Department of Psychiatry, Warneford Hospital, Oxford, UK.; Oxford Health NHS Foundation Trust, Oxford, UK., Browning M; Department of Psychiatry, Warneford Hospital, Oxford, UK. michael.browning@psych.ox.ac.uk.; Oxford Health NHS Foundation Trust, Oxford, UK. michael.browning@psych.ox.ac.uk.
Publikováno v:
Current topics in behavioral neurosciences [Curr Top Behav Neurosci] 2024; Vol. 66, pp. 49-65.
Autor:
Kaltenboeck A; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria., Halahakoon DC; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Harmer CJ; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Cowen P; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, United Kingdom., Browning M; Department of Psychiatry, University of Oxford, Oxford, United Kingdom.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford, United Kingdom.
Publikováno v:
The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2022 Sep 28; Vol. 25 (9), pp. 720-726.
Autor:
Martens MAG; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.; Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford OX3 7JX, UK., Kaltenboeck A; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.; Clinical Division of Social Psychiatry, Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna General Hospital, 1090 Vienna, Austria., Halahakoon DC; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK., Browning M; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK., Cowen PJ; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK., Harmer CJ; Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford OX3 7JX, UK.; Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford OX3 7JX, UK.; Oxford Health NHS Foundation Trust, Warneford Hospital, Oxford OX3 7JX, UK.
Publikováno v:
Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Aug 14; Vol. 14 (8). Date of Electronic Publication: 2021 Aug 14.
Autor:
Halahakoon DC; Institute of Cognitive Neuroscience, University College London, London, England.; Department of Psychiatry, University of Oxford, Oxford, England., Kieslich K; Institute of Cognitive Neuroscience, University College London, London, England., O'Driscoll C; Division of Psychiatry, University College London, London, England., Nair A; Max Planck Centre for Computational Psychiatry and Aging Research, University College London, England.; Institute of Psychiatry, Psychology and Neuroscience, Kings College London, London, England., Lewis G; Division of Psychiatry, University College London, London, England., Roiser JP; Institute of Cognitive Neuroscience, University College London, London, England.
Publikováno v:
JAMA psychiatry [JAMA Psychiatry] 2020 Dec 01; Vol. 77 (12), pp. 1286-1295.
Autor:
Nord CL; Institute of Cognitive Neuroscience, University College London, London, UK. Camilla.Nord@mrc-cbu.cam.ac.uk.; MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK. Camilla.Nord@mrc-cbu.cam.ac.uk., Halahakoon DC; Institute of Cognitive Neuroscience, University College London, London, UK.; Department of Psychiatry, University of Oxford, Oxford, UK., Limbachya T; Camden and Islington NHS Foundation Trust, London, UK., Charpentier C; Institute of Cognitive Neuroscience, University College London, London, UK.; Division of the Humanities and Social Sciences, California Institute of Technology, California, USA., Lally N; Institute of Cognitive Neuroscience, University College London, London, UK.; Warwick Medical School, University of Warwick, Coventry, UK.; Experimental Therapeutics & Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA., Walsh V; Institute of Cognitive Neuroscience, University College London, London, UK., Leibowitz J; Camden and Islington NHS Foundation Trust, London, UK., Pilling S; Camden and Islington NHS Foundation Trust, London, UK.; Department of Clinical, Educational, and Health Psychology, University College London, London, UK., Roiser JP; Institute of Cognitive Neuroscience, University College London, London, UK.
Publikováno v:
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology [Neuropsychopharmacology] 2019 Aug; Vol. 44 (9), pp. 1613-1622. Date of Electronic Publication: 2019 Apr 30.